ZOLGENSMA INCAL Trademark
Trademark Overview
On Monday, January 29, 2024, a trademark application was filed for ZOLGENSMA INCAL with the United States Patent and Trademark Office. The USPTO has given the ZOLGENSMA INCAL trademark a serial number of 79392220. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, August 9, 2024. This trademark is owned by Novartis AG. The ZOLGENSMA INCAL trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression
General Information
| Serial Number | 79392220 |
| Word Mark | ZOLGENSMA INCAL |
| Filing Date | Monday, January 29, 2024 |
| Status | 638 - NEW APPLICATION - ASSIGNED TO EXAMINER |
| Status Date | Friday, August 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations and gene therapy products in the nature of injectable biologic preparations for genetic, neurological, motor neuron, or neuromuscular diseases, disorders and conditions; pharmaceutical preparations and gene therapy products in the nature of biological preparations containing genetic materials for treating spinal muscular atrophy, loss of motor neurons, muscle degeneration, muscle weakness, and paralysis; gene therapy preparations in the nature of biological preparations containing genetic materials for sustained survival motor neuron protein expression |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 29, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Novartis AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | CH |
Trademark Events
| Event Date | Event Description |
| Thursday, March 28, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 29, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 8, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 8, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, April 8, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 8, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 8, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, April 8, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, August 9, 2024 | ASSIGNED TO EXAMINER |
| Tuesday, April 2, 2024 | APPLICATION FILING RECEIPT MAILED |
